Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 252.50
Bid: 252.00
Ask: 253.00
Change: 0.50 (0.20%)
Spread: 1.00 (0.397%)
Open: 257.50
High: 257.50
Low: 251.50
Prev. Close: 252.00
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Mar 2024 13:54

RNS Number : 7652I
Spire Healthcare Group PLC
28 March 2024
 

28 March 2024

 

Spire Healthcare Group plc (the Company)

 

Exercise of Executive Share Plan awards

On 26 March 2024, Justin Ash and Jitesh Sodha, both Executive Directors of the Company, exercised their vested:

· Long Term Incentive Plan awards in the Company that were granted on 25 March 2019 (the 2019 LTIP award). 2019 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2021 Annual Report and Accounts. On vesting in March 2022, the 2019 LTIP awards were subject to a further two-year holding period which ended in March 2024; and

· Deferred Share Bonus Plan awards that were granted on 18 March 2021 (the 2021 DSBP award). 2021 DSBP awards were subject to a three-year holding period which ended on the third anniversary of the award being made.

 

Following the exercise by both Directors of their 2019 LTIP awards and 2021 DSBP awards over ordinary shares in the Company and after the satisfaction of taxes due, both decided to retain the balance of ordinary shares as follows:

 

 

Share plan and type of award

Shares vested and exercised

Shares retained following satisfaction of taxes due

Justin Ash

2019 LTIP (in the form of nil-cost options)

 

373,263

197,829

Justin Ash

 

2021 DSBP (in the form of nil-cost options)

 

97,251

51,543

Total number of shares retained

249,372

 

Following the transactions, Justin Ash holds 827,640 ordinary shares in the Company.

 

 

Share plan and type of award

Shares vested and exercised

Shares retained following satisfaction of taxes due

Jitesh Sodha

2019 LTIP (in the form of nil-cost options)

 

239,738

127,061

Jitesh Sodha

 

2021 DSBP (in the form of nil-cost options)

 

41,637

22,067

Total number of shares retained

149,128

 

Following the transactions, Jitesh Sodha holds 283,186 ordinary shares in the Company.

 

The exercise of a vested 2019 LTIP award by John Forrest and a vested Long Term Incentive Plan award that were granted on 18 March 2021 by Harbant Samra, both PDMRS of the Company, are disclosed below.

 

Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justinian Joseph Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Ash of his award over 373,263 ordinary shares and after the satisfaction of taxes due, a balance of 197,829 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

373,263

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Jitesh Himatlal Sodha

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Sodha of his award over 239,738 ordinary shares and after the satisfaction of taxes due, a balance of 127,061 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

239,738

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justinian Joseph Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Deferred Share Bonus Plan 2014.

 

Following the exercise by Mr Ash of his award over 97,251 ordinary shares and after the satisfaction of taxes due, a balance of 51,543 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

97,251

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Jitesh Himatlal Sodha

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Deferred Share Bonus Plan 2014.

 

Following the exercise by Mr Sodha of his award over 41,637 ordinary shares and after the satisfaction of taxes due, a balance of 22,067 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

41,637

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

John Joseph Forrest

2

Reason for the notification

a)

Position/status

 

Chief Operating Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Forrest of his award over 133,525 ordinary shares and after the satisfaction of taxes due, a balance of 70,768 ordinary shares were sold at £2.32.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

£2.32

133,525

70,768

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Harbant Singh Samra

2

Reason for the notification

a)

Position/status

 

Deputy Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Samra of his award over 59,589 ordinary shares and after the satisfaction of taxes due, a balance of 31,582 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

59,589

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDXXUDDGSI
Date   Source Headline
1st Dec 202210:02 amRNSTotal Voting Rights
1st Nov 20221:24 pmRNSTotal Voting Rights
14th Oct 202210:00 amRNSChanges to Board of Directors and committees
3rd Oct 20224:04 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSBlock Listing Six Monthly Return
8th Sep 20227:00 amRNSInterim Results
1st Sep 20229:51 amRNSTotal Voting Rights
23rd Aug 20222:55 pmRNSHolding(s) in Company
15th Aug 20227:00 amRNSNotice of Interim Results
4th Aug 20222:11 pmRNSHolding(s) in Company
1st Aug 20222:43 pmRNSTotal Voting Rights
19th Jul 20229:07 amRNSBlock listing Interim Review
14th Jul 20223:48 pmRNSHolding(s) in Company
13th Jul 20224:43 pmRNSHolding(s) in Company
6th Jul 20224:00 pmRNSDirector/PDMR Shareholding
1st Jul 202210:28 amRNSTotal Voting Rights
29th Jun 20223:56 pmRNSHolding(s) in Company
29th Jun 20227:00 amRNSCapital Markets Event and new agreement with BUPA
1st Jun 20227:54 amRNSTotal Voting Rights
19th May 20227:44 amRNSHolding(s) in Company
18th May 20223:15 pmRNSHolding(s) in Company
13th May 202210:43 amRNSDirector/PDMR Shareholding
11th May 20224:25 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
6th May 20227:00 amRNSNotice of Capital Markets Day
3rd May 20228:46 amRNSTotal Voting Rights
27th Apr 20223:49 pmRNSDirector/PDMR Shareholding
6th Apr 20229:55 amRNSDirector/PDMR Shareholding
1st Apr 20224:40 pmRNS2021 Annual Report and 2022 Notice of AGM
1st Apr 202212:32 pmRNSHolding(s) in Company
1st Apr 202211:10 amRNSTotal Voting Rights
25th Mar 20222:51 pmRNSBlock listing application
24th Mar 20225:16 pmRNSHolding(s) in Company
16th Mar 20228:07 amRNSDirector/PDMR Shareholding
9th Mar 20227:43 amRNSHolding(s) in Company
4th Mar 20226:12 pmRNSHolding(s) in Company
4th Mar 20223:14 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20227:23 amRNSTotal Voting Rights
25th Feb 202212:21 pmRNSHolding(s) in Company
25th Feb 20227:00 amRNSRe-financing of funding facilities
22nd Feb 20223:26 pmRNSHolding(s) in Company
22nd Feb 20221:38 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSManagement update
8th Feb 20227:00 amRNSNotice of Preliminary Results
1st Feb 20229:29 amRNSTotal Voting Rights
27th Jan 20222:57 pmRNSTotal Voting Rights
18th Jan 20227:00 amRNSUpdate on shareholder views
13th Jan 20224:52 pmRNSHolding(s) in Company
12th Jan 20222:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.